Raymond James Downgrades Sierra Bancorp to Market Perform

Raymond James analyst Donald Worthington downgrades Sierra Bancorp (NASDAQ:BSRR) from Outperform to Market Perform.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Raymond James analyst Donald Worthington downgrades Sierra Bancorp (NASDAQ:BSRR) from Outperform to Market Perform.

Alliance Global Partners Upgrades Rimini Street to Buy, Announces $8.5 Price Target

By Benzinga Newsdesk

Today, 8:50 AM

Alliance Global Partners analyst Brian Kinstlinger upgrades Rimini Street (NASDAQ:RMNI) from Neutral to Buy and announces $8.5 price target.

RMNI

Cannabis Global Financial Results For The Quarter Show Staggering Revenue Growth Of 2,330% YoY

By Vuk Zdinjak

Today, 8:50 AM

Cannabis Global, Inc. (OTC: CBGL) announced financial and operational performance data for the three months ended February 28, 2022.

CBGL

Sabre Says Partners With GOPASS Global To Mitigate Travel Risks While Increasing Confidence To Travel

By Benzinga Newsdesk

Today, 8:50 AM

Sabre Corporation (NASDAQ:SABR), a leading software and technology provider that powers the global travel industry, has partnered with travel risk management platform GOPASS Global to help deliver its game-changing

SABR

Lexicon Pharma’s Pain Candidate Fails In Postherpetic Neuralgia Study

By Vandana Singh

Today, 8:50 AM

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) announced the topline results of RELIEF-PHN-1 Phase 2 proof-of-concept study of LX9211 in postherpetic neuralgia, a lasting pain in the areas of the skin that had shingles.

LXRX

Raymond James Downgrades Sierra Bancorp to Market Perform

Related Posts

Alliance Global Partners Upgrades Rimini Street to Buy, Announces $8.5 Price Target

Cannabis Global Financial Results For The Quarter Show Staggering Revenue Growth Of 2,330% YoY

Sabre Says Partners With GOPASS Global To Mitigate Travel Risks While Increasing Confidence To Travel

Lexicon Pharma’s Pain Candidate Fails In Postherpetic Neuralgia Study